نتایج جستجو برای: associated domain family 1 rassf1a

تعداد نتایج: 4419053  

2015
Nikola Vlahov Simon Scrace Manuel Sarmiento Soto Anna M. Grawenda Leanne Bradley Daniela Pankova Angelos Papaspyropoulos Karen S. Yee Francesca Buffa Colin R. Goding Paul Timpson Nicola Sibson Eric O’Neill

Tumor progression to invasive carcinoma is associated with activation of SRC family kinase (SRC, YES, FYN) activity and loss of cellular cohesion. The hippo pathway-regulated cofactor YAP1 supports the tumorigenicity of RAS mutations but requires both inactivation of hippo signaling and YES-mediated phosphorylation of YAP1 for oncogenic activity. Exactly how SRC kinases are activated and hippo ...

Journal: :International journal of oncology 2008
Jia-Jing Lee Janos Geli Catharina Larsson Göran Wallin Mohsen Karimi Jan Zedenius Anders Höög Theodoros Foukakis

Genome-wide hypomethylation and hypermethylation at CpG promoters are common in cancer. To date, little is known about global methylation changes in follicular thyroid cancer (FTC). Two independent quantitative methods, bisulphite Pyrosequencing of Long Interspersed Nucleotide Elements-1 (LINE-1) and LUminometric Methylation Assay (LUMA) were used to quantify genome-wide methylation in 21 FTC a...

2010
C. Matuschek E. Bölke G. lammering P. a. Gerber M. Peiper w. Budach H. taskin H. B. Prisack G. Schieren K. orth H. Bojar

Background: tumor-related methylated dna and circulating tumor cells (CtC) in the peripheral blood might be of prognostic importance in breast cancer. thus, the aim of our study was to examine free methylated dna and CtC in the blood from breast cancer patients and to correlate it with clinicopathological features known to influence prognosis. Materials and Methods: we prospectively obtained se...

2017
Lydia Giannopoulou Issam Chebouti Kitty Pavlakis Sabine Kasimir-Bauer Evi S. Lianidou

The RASSF1A promoter is frequently methylated in high-grade serous ovarian cancer (HGSC). We examined RASSF1A promoter methylation in primary tumors, adjacent morphologically tumor cell-free tissues and corresponding circulating tumor DNA (ctDNA) samples of patients with HGSC, using a real-time methylation specific PCR (real-time MSP) and a methylation-sensitive high-resolution melting analysis...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Essel Dulaimi Jeanne Hillinck Inmaculada Ibanez de Caceres Tahseen Al-Saleem Paul Cairns

PURPOSE Breast cancer is the most common malignancy in American women and the second leading cause of death from cancer. The genetic and epigenetic alterations that initiate and drive cancer can be used as targets for detection of neoplasia in bodily fluids. Tumor cell-specific aberrant promoter hypermethylation can be detected in nipple aspirate and ductal lavage from breast cancer patients. I...

2004
Jie Wang J. Jack Lee Luo Wang Diane D. Liu Charles Lu You-Hong Fan Waun Ki Hong Li Mao

The p16 and RASSF1A are tumor suppressor genes frequently inactivated by de novo promoter hypermethylation in non-small cell lung cancer. We studied 119 patients with non-small cell lung cancer (70 stage I/II and 49 stage IIIA) who had undergone surgery with curative intent. The p16 and RASSF1A promoter methylation statuses were determined by methylation-specific PCR. Statistical analyses, all ...

Journal: :Journal of the National Cancer Institute 2001
D G Burbee E Forgacs S Zöchbauer-Müller L Shivakumar K Fong B Gao D Randle M Kondo A Virmani S Bader Y Sekido F Latif S Milchgrub S Toyooka A F Gazdar M I Lerman E Zabarovsky M White J D Minna

BACKGROUND The recently identified RASSF1 locus is located within a 120-kilobase region of chromosome 3p21.3 that frequently undergoes allele loss in lung and breast cancers. We explored the hypothesis that RASSF1 encodes a tumor suppressor gene for lung and breast cancers. METHODS We assessed expression of two RASSF1 gene products, RASSF1A and RASSF1C, and the methylation status of their res...

2015
Søren Kristiansen Lars Mønster Jørgensen Morten Høgh Hansen Dorte Nielsen György Sölétormos

The serological protein tumor markers CA 15-3, CEA, and TPA are frequently used to monitor tumor burden among metastatic breast cancer patients. Breast cancer is associated with global DNA hypomethylation and hypermethylation of some promoter regions. No monitoring study has yet investigated the interrelationship between protein tumor markers, the global DNA hypomethylation, and hypermethylated...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Janine Stutterheim Fatima Ait Ichou Emmy den Ouden Rogier Versteeg Huib N Caron Godelieve A M Tytgat C Ellen van der Schoot

PURPOSE PCR-based detection of minimal residual disease (MRD) in neuroblastoma (NB) is presently based on NB-specific transcripts. However, the expression of these targets varies between patients and upon treatment, and only PHOX2B is truly specific. RASSF1a is methylated (RASSF1a(M)) in NB, and we investigated whether it can serve as a specific and stable DNA MRD marker. PATIENTS AND METHODS...

Journal: :Cancer research 2002
Undraga Schagdarsurengin Oliver Gimm Cuong Hoang-Vu Henning Dralle Gerd P Pfeifer Reinhard Dammann

Loss of heterozygosity of chromosome 3p21 is one of the most frequent alterations in solid tumors, including thyroid carcinomas. Recently, we have characterized the novel tumor suppressor gene RASSF1 located in this locus. The RASSF1A isoform is epigenetically inactivated in a variety of human primary tumors. In this study, we investigated the expression and methylation status of the RASSF1 gen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید